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L-Phenylalanine Biosensor in Saccharomyces cerevisiae 
Abstract: 
In vivo biosensors can be used for the detection of intracellular and extracellular stimuli 
leading to a reporter molecule response. Biosensors are becoming increasingly popular in 
synthetic biology and metabolic engineering for implementation in synthetic pathways to 
control the expression of reporter genes in response to specific metabolites or external 
tors. In vivo biosensors are generally divided into three categories: transcription-based, 
translation-based and post-translational biosensors. L-phenylalanine is one of the most 
demanded amino acids and it faces an increasing commercial interest since it is a precursor 
metabolite for flavonoids and other chemicals including the artificial sweetener aspartame, 
vanillin, aromadedrin, rutin and many others. Therefore, it is of interest in various 
tries such as pharmaceutical, cosmetic and biotechnology. L-phenylalanine is one of the 
aromatic amino acids yielded from the Shikimate pathway, also including tyrosine and 
tryptophan. In this paper the author constructed a transcription factor-based L-
phenylalanine biosensor in the yeast Saccharomyces cerevisiae. The newly constructed 
strain has two genetic constructs integrated into its genome. First construct uses 
tional regulatory protein TyrR which forms a dimer only in the presence of L-
phenylalanine. The dimer later binds to a TYR strong box sequence in the CYC1p_T1 
promoter region of the second construct initiating green fluorescent protein production 
resulting in a fluorescent signal. 
Keywords: 
L-phenylalanine, biosensor, Saccharomyces cerevisiae, transcription factor, TyrR 
ry protein, Shikimate pathway, flavonoids. 
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L-fenüülalaniini biosensor pärmis Saccharomyces cerevisiae 
Lühikokkuvõte: 
In vivo biosensoreid võimaldavad detekteerida kindlaid rakusiseseid või -väliseid 
stiimuleid ning reageerida neile mõne soovitud molekulaarse vastusega. Biosensorite 
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kasutamine on tänu sünteetilise bioloogia ning metaboolse inseneerimise metoodikate 
arengule pidevalt kasvanud, sest võimaldab kontrollida ning reguleerida soovitud valkude 
või metaboliitide tasemeid rakus. In vivo biosensorid jagatakse tavaliselt kolmeks: (i) 
transkriptsiooni-põhised, (ii) translatsiooni-põhised ning (iii) translatsiooni-järgsed 
biosensorid. L-fenüülalaniin on aminohape ning prekursor-molekul näiteks flavanoididele 
– keemiliste elementide grupile, kuhu kuuluvad ka kunstlik magusaine aspartaam, vaniliin, 
aromadedriin, rutiin ning paljud teised kemikaalid. Seetõttu on sel molekulile suur 
kommertsiaalne huvi nii farmaatsias, kosmeetika-tööstuses kui  biotehnoloogias. L-
fenüülalaniini biosünteesitakse Sikimaadi rajas, mis toodab ka teisi aromaatseid 
aminohappeid nagu türosiin ja trüptofaan. Käesolevas lõputöös kirjeldatakse 
transkriptsioonifaktori meetodil põhinevat L-fenüülalaniini biosensori konstrueerimist 
pärmis Saccharomyces cerevisiae. Uudset biosensorit sisaldava pärmi tüve genoomi on 
lisatud kaks uut kostrukti. Esimene konstrukt kasutab transkriptsiooni regulaator-valku 
TyrR, mis moodustab dimeerse kompleksi vaid L-fenüülalaniini juuresolekul. Dimeerne 
TyrR kompleks on aga võimaline seonduma TYR ‟strong box‟ järjestusega CYCp_T1 
promootor-regioonis teise kontruktiga, mis seejärel initsieerib rohelise floresentsvalgu 
sünteesi, mis ongi disainitud biosensori väljund-signaal. 
 
Võtmesõnad: 
L-fenüülalaniini, biosensor, Saccharomyces cerevisiae, transkriptsioon faktor, TyrR 
reguleeriv valku, Shikimaalne rada, flavonoidid. 
CERCS: T490 
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TERMS, ABBREVIATIONS AND NOTATIONS 
L-Phe – L-phenylalanine aromatic amino acid 
L-Tyr – L-tyrosine aromatic amino acid 
L-Trp – L-tryptophan aromatic amino acid 
LB – lysogeny broth nutritionally rich medium 
YPD – yeast extract peptone dextrose medium 
DELFT – minimalistic mineral medium 
PEP – phosphoenolpyruvate  
E4P – erythrose 4-phosphate 
DAHP – 3-Deoxy-D-arabino-heptulosonic acid 7-phosphate 
UV – ultraviolet electromagnetic radiation 
PAL –phenylalanine-ammonia-lyase 
C4H –cinnamate 4-hydroxylase 
4CL – 4-coumarate: CoA ligase 
AD – Alzheimer‟s disease 
NDM1 – New Delhi metallo-β-lactamase-1 
BACE1 – β active site-cleavage enzyme-1 
TF – transcription factor  
TR – transcriptional regulator 
RNA – ribonucleic acid 
DNA – deoxyribonucleic acid  
GFP – green fluorescent protein 
Xgal – 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside 
lacZ – b-galactosidase 
CCM – cis,cis-muconic acid 
HPLC – high pressure liquid chromatography 
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αCTD – C-terminal domain of alpha subunit of the RNA polymerase 
LTTR – LysR-type transcriptional regulator 
ATP – adenosine triphosphate 
T1 – the first TATA box region of the CYC1p promoter DNA sequence 
CYC1p – cytochrome c isoform 1 promoter 
CYC1t – cytochrome c isoform 1 terminator 
pFCY2 – purine-cytosine permease promoter  
tADH1 – alcohol dehydrogenase promoter 
TyrR – Tyr tyrosinase regulon 
AMP – ampicillin 
LEU – amino acid leucine 
HIS – histidine  
V – volts 
mA – miliampers  
G – gravitational force of earth 
rpm – rotations per minute 
min – minutes 
sec – seconds  
h – hour  
bp – DNA base pairs 
kB – DNA kilobases (1 kb = 1000 bp) 
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INTRODUCTION 
The aromatic amino acid L-phenylalanine is one of the three amino acids including L-
tyrosine and L-tryptophan which is yielded from the shikimate metabolic pathway and is 
later derived into various flavonoids like naringenin, aspartame and vanillin or other aro-
matic derivatives by use of the phenylpropanoid metabolic pathway. In order to produce 
these molecules industrially a number of microorganisms are being used including 
Saccharomyces cerevisiae yeast. 
The problem is that there have been no previous biosensors developed for sensing the 
concentrations of L-phenylalanine in yeast which is a key molecule in production of 
phenypropanoid pathway products. This means that selection of best phenotypes for the 
overproduction of L-phenylalanine and thus its downstream dervatives uses expensive, 
labor intense and time consuming methods such as high pressure liquid chromatography 
analysis. Luckily there have been previous attempts in constructing biosensors which 
employ bacterial transcriptional activators in yeast and a functional design template was 
made. It is also known that L-phenylalanine biosensors in E. coli have been made where a 
functional transcription activating sequence and a transcriptional activator where 
identified. The transcription factor identified is the TyrR regulon which regulates the 
aromatic amino acid biosynthesis via the Shikimate pathway. The transcription activating 
sequence was a so called TyrR strong box which can activate gene transcription in the 
presence of L-phenylalanine. 
The goal of this research was to identify a functional L-phenylalanine biosensor design for 
S. cerevisiae and construct it. It was determined that the biosensor should consist of two 
genetic constructs. One containing a TyrR regulon capable of dimerising and binding 
specific transcriptional activation binding sites in the presence of L-phenylalanine under 
the control of different promoters. The second construct contains a green fluorescent 
protein coding sequence controlled by a CYC1p promoter with a TyrR strong box 
integrated in its first TATA box position. 
All goals where not achieved but multiple strides were made towards the biosensor 
assembly in S.cerevisiae. The author hopes the current biosensor design can be further 
tested and implemented for use in the laboratories. 
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1 LITERATURE REVIEW 
1.1 Biosynthesis of L-phenylalanine 
The shikimate metabolic pathway (Figure 1.) is only found in microorganisms and plants, 
but never in mammals which makes this pathway highly interesting for production of 
herbicides, antibiotics and live vaccines. It links the carbohydrate metabolism with the 
biosynthesis of aromatic amino acids (L-phenylalanine, L-tryptophan and L-tyrosine) and 
their secondary metabolites. The common precursor for all aromatic amino acids is 
chorismate which is produced from central carbon metabolism derivatives phosphoenolpy-
ruvate (PEP) which comes from the glycolysis pathway  and erythrose 4-phosphate (E4P) 
yielded from the pentose phosphate pathway. Chorismate is produced via seven metabolic 
steps in the shikimate pathway from the precursors. In microorganisms this pathway is 
regulated by the repression of its initial enzymes and by feedback inhibition. The carbon 
flow into the shikimate pathway for bacteria is controlled by feedback inhibition of aro-
matic amino acid-sensitive DAHP synthase isoenzymes which is in charge of the initial 
PEP and E4P concentration into a heterocyclic compound named 3-Deoxy-D-arabino-
heptulosonate7-phosphate also known as DAHP which gets eventually metabolised into 
chorismate. Since L-phenylalanine and L-tyrosine have similar molecular structures, L-
tyrosine has an extra hydroxide group on its hexane ring whereas L-phenylalanine does 
not, they are both a part of the same branch off point in chorismite metabolism. Chorismate 
is metabolised into prophenate by chorismite mutase, which is metabolised into either 4-
hydroxyphenylpyruvate by prephenate dehydrogenase or into phenylpyruvate by prephen-
ate dehydratase. The aromatic amino acid L-tyrosine is produced from 4-
hydroxyphenypyruvate which is catalysed by tyrosine transaminase whereas L-
phenylalanine is produced from phenylpyruvate with the help of phenylalanine transami-
nase (Bentley, 1990), (Herrmann and Weaver, 2002), (Herrmann, 2007), (Gosset, 2009). 
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Figure 1. Biosynthesis of L-phenylalanine via Shikimate metabolic pathway in S. cerevisiae. 
 
1.2 L-phenylalanine derived high-value products 
The aromatic amino acid L-phenylalanine is a highly demanded amino acid as its deriva-
tives account for 1 billion US dollars in sales (Sprenger, 2007). The derivatives of L-
phenylalanine are yielded via the phenylpropanoid pathway (Figure 2.) which supplies 
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plants with a large variety of phenolic compounds involved in a wide range of functions 
ranging from plant protection from ultraviolet (UV) radiation, antimicrobial effects, antim-
icrobial activity and signal transduction. The core phenylpropanoid pathway (PHENYL-
PROPANOID PATHWAY) degrades phenylalanine into 4-coumaroyl-CoA which is a 
central precursor for most flavonoids produced from this pathway (Hahlbrock and Scheel, 
1989). The degradation happens in three enzymatic reactions. Initially phenylalanine-
ammonia-lyase (PAL) catalyses the nonoxidative deamination of L-phenylalanine into 
cinnamic acid (MacDonald and D‟Cunha, 2007). Next cinnamic acid is converted into 4-
coumaric acid by cinnamate 4-hydroxylase (C4H) by attaching a hydroxide group to cin-
namic acids fourth carbon (4C) of its phenyl group. The last reaction of the core phenyl-
propanoid pathway forms 4-coumaroyl-CoA from 4-coumaric acid with the help of 4-
coumarate: CoA ligase (4CL) which forms a thiol ester in the place of the carboxyl group 
(Hahlbrock and Scheel, 1989). 
The phenylpropanoid Pathway has multiple branching off points. One of which is the 
branch off point at which uses into 4-coumaric acid and 4-coumaroyl-CoA for lignin pro-
duction. The enzyme chalcone synthase uses 4-coumaroyl-CoA and malonyl-CoA from the 
fatty acid biosynthesis pathway and uses the three acetate units of malonyl-CoA to con-
dense the into a new aromatic ring and thus forming naringenin chalcone.  Naringenin 
chalcone is the basis for synthesizing all major flavonoid subgroups flavones, flavanoles, 
tannins, anthocyanins and isoflavones. (Panche, Diwan and Chandra, 2016), (Weisshaar 
and Jenkinst, 1998). 
 
Figure 2. Phenylpropanoid metabolic pathway. 
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Some particularly interesting compounds for humans include rutin, aromadedrin, gink-
getin, naringenin, quercetin, myricetin and aspartame. Rutin has been shown to have poten-
tial in the treatment of diabetes because of its ability to inhibit aldose reductase which is 
known for causing diabetic complications. Aromadedrin has been found to inhibit lipoxy-
genase which is involved in causing inflammation. So aromadedrin is being researched as a 
potent drug for treating inflammation. Ginkgetin has been found to have antiplatelet effects 
in humans. Naringenin has been found to be a potent antimicrobial inhibitor and is being 
researched as a potential antibiotic. Quercetin is being researched as a potential antibiotic 
against superbugs which are New Delhi metallo-β-lactamase-1 (NDM-1) positive and cur-
rently have no known antibiotics against them. Myricetin inhibits β active site-cleavage 
enzyme-1 (BACE-1) activity which is known to be involved in causing Alzheimer‟s dis-
ease (AD) so it is being researched for its potential in AD treatment. (Panche, Diwan and 
Chandra, 2016) Aspartame is a natural sweetener with roughly the same amount of calories 
per gram as sucrose, but it is almost 200 times sweeter then sucrose thus the amount re-
quired to reach the same level of sweetness is much less which makes it useful as an artifi-
cial sweetener with low calories (Suzuki, 2013).  
This shows that construction of biosensors for sensing key molecules in these pathways 
would be beneficial for improving target compound production in microbial strains of in-
terest. The amino acid L-phenylalanine seems to be the best option since it is the interme-
diate of both metabolic pathways described above and could serve as an optimal target 
molecule for detection. 
1.3 Biosensors 
The term “biosensor” describes a wide range of analytical devices containing a biological 
sensing element with a wide range of applications including drug discovery, environmental 
monitoring, biomedicine, industrial biotechnology and the list goes on. The first biosensor 
was created around five decades ago and was designed to measure glucose concentrations 
in a sample with the help of an immobilized glucose oxidase electrode (Clark and Lyons, 
1962).  In vivo biosensors can generally be divided into three main categories depending 
on at which stage of the central dogma of molecular biology they operate on whether its 
transcriptional, translational or the post-translational stage of protein synthesis from DNA. 
Usual reporters used in in vivo biosensors to produce an observable output signal are fluo-
rescence, bioluminescence and colour change (Goers et al., 2013).  
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Transcription factors function by regulating cellular gene expression depending on specific 
metabolite concentrations present intra- and extracellularly. These properties have made 
TF‟s ideal to be exploited for in vivo biosensor construction since they allow for real-time 
monitoring of production of specific target molecules (Shi, Ang and Zhao, 2018). Such 
biosensors allow measurement of small deviations in ligand concentrations which lead to 
large changes in protein abundance thanks to amplification through transcription and thus 
allows for a wide dynamic range and high sensitivity of the biosensor (Goers et al., 2013).  
Transcription based biosensor usually employ promoters which are activated by transcrip-
tion factors or other signalling cascades. Their response time in majority of the cases is 
measured in hours and the metabolic burden they pose to the cell is comparatively small 
since the reporter molecules are only expressed in the presence of an inducer (transcription 
factor), overexpression of the relevant transcription factor is often necessary when using 
non-native TF‟s whereas when using endogenous TF‟s overexpression might be unneces-
sary. They are quite specific, but such biosensors have some minor issues like the final 
output does not exactly correlate with the target molecule concentration because of down-
stream steps in protein synthesis thus the output signal can be linked to gene expression of 
the target gene. The construction of such biosensors is relatively easy since they can be 
constructed from pre-existing genetic components and plasmids. In order to properly char-
acterize the constructed biosensor a negative control cell line is highly advisable in order to 
define the proper functional range and reporter protein characteristics. There are two op-
tions for negative control cell lines. First is a wild-type cell line without the construct re-
quired for biosensor functionality integrated, but this option provides only absolute meas-
urements of cell growth and expression characteristics at different test conditions. The sec-
ond option is using a promoter reference standard, which is essentially the same construct, 
but without the possibility of TF binding to the promoter activating reporter gene transcrip-
tion which allows for ratiometric relative measurements thus allowing for better biosensor 
characterization (Goers et al., 2013) 
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Figure 3. Transcription factor – based biosensor mechanism of action. 
Translation based biosensors which are essentially RNA switches, are designed to give a 
measurable output signal in the presence of the target of interest and generally have faster 
response times and smaller metabolic burden to the cells in comparison with transcription-
based biosensor designs since RNA folding is universal between different organisms. In 
general, such biosensors have three functional domains where one receives the signal, sec-
ond processes the signal and third produces a measurable output signal. The signal receiver 
is an aptamer domain which recognises and specifically binds a target molecule thanks to 
RNA forming specific secondary and tertiary structures in the presence of the target. The 
second step (signal processing) happens when the switch domain of the RNA molecule 
changes the processing intensity, translation rate or stability of the device in response to 
target binding to the aptamer domain. The third domain opens up and allows for translation 
of a target reporter protein in the presence of the bound target molecule thus producing a 
measurable output signal (Goers et al., 2013). 
Post-translational biosensors function on the protein basis which are constitutively pro-
duced in the cells but are only activated when a target molecule is present thus producing a 
measurable output signal. Such biosensor designs are very varied in comparison to tran-
scription and translation-based biosensor designs because of the wide protein diversity and 
function range available in nature, thus an exact design strategy cannot be given since it 
largely depends on the specific cases of each biosensor and the molecular mechanisms 
employed, but a good examples are enzymes catalysing target reactions employing one or 
more secondary substrates to produce an output signal in the presence of a target molecule 
(Goers et al., 2013). 
Fluorescence based reporters are fluorescent proteins such as GFP and many others. They 
produce a fluorescent output of a predetermined wavelength after being excited by light of 
a different wavelength thus allowing excited electrons to jump from a higher energy level 
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to a lower one by emitting light. These proteins offer an output signal with high sensitivity 
and specificity. By using various fluorescent proteins with different colours it is possible 
monitor various parameters inside the cell simultaneously (Goers et al., 2013). In vivo 
fluorescent proteins have been in the forefront of understanding various biological proc-
esses such as observing various metabolic pathway functions inside the cells (Kunzelmann, 
Solscheid and Webb, 2014), imaging of fixed cells using fluorescent-tagged antibodies 
(Oldach and Zhang, 2014), mitochondrial physiology (De Michele, Carimi and Frommer, 
2014) and for visualization of various other celullar processes. Overall fluorescnence has 
helped visualize most of the experiments involving cells since the first introduction of 
fluorescent proteins. These methods have helped in developing biosensors which exploit 
small molecule/metabolite binding transcriptional factors, second messengers and proteins. 
In such biosensors the concentration of specific metabolites intracellular concentrations 
which are either directly or indirectly proportional to the GFP (or any other fluorescent 
protein) fluorescence intensity (Goers et al., 2013).   
Bioluminescent proteins, e.g. firefly luciferase, are used similarly as fluorescent proteins, 
but the mechanism of function differs. Proteins from this class do not emit the light 
themselves as fluorescent proteins do, but rather they act as enzymes which catalyze 
chemical reactions leading to a bioluminescent light emission thus the substrate meant for 
catalysis by these proteins needs to be provided (Goers et al., 2013).  
Biosensors that are design to be used for on the field applications the most suitable reporter 
type is most often colour change which eliminates the need for expensive scientific devices 
for measuring output signal like in the cases of fluorescence and bioluminescence. Such 
systems have a wider range in terms of their mechanism of action, but in majority of cases 
it requires the addition of a substrate which can be chemically converted into a related 
compund which produces colour. The most often used colour change reporters include the 
chromogenic compound 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (Xgal) and b-
galactosidase (lacZ) gene (Goers et al., 2013).  
1.4 Host system 
The baker‟s yeast formally known as Saccharomyces cerevisiae is the most widely used 
microorganism species in the biotechnology industry worldwide and over exceeds the use 
of other microorganisms in terms of cell weight produced per year by over two folds. Be-
cause of the quickly depleting natural non-renewable resources such as petrochemicals and 
rapidly changing environmental factors thus ever increasing the need for sustainable and 
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renewable sources yeast has gained renewed interest as production source for various 
chemicals used in both traditional markets such as food, agriculture, feed and also for the 
production of specific biocatalysts used in pharmaceutical and fine chemical synthesis in-
dustries since the usual chemical synthesis methods traditionally employed in them often 
require the use of  low activity catalysts providing small yields of target compounds and 
use of chemicals derived from the petrol industry which is a finite source. Whereas natu-
rally produced catalysts can be evolved using various adaptive evolution techniques to 
cause the microorganism to increase activities of certain enzymes or even evolve new cata-
lytic activities previously not seen in nature if correct constraints have been chosen. The 
potential of yeast in the biotechnology industry and biochemical synthesis is ever expand-
ing and not yet fully understood (Johnson and Echavarri-Erasun, 2011). Yeast has been 
used in metabolic engineering from the start since it is a model organism. Studies have 
shown that yeast is a favourable microorganism for over production of phenylpropanoid 
pathway derivatives with increased yields in comparison with the native host species of 
these aromatic molecules such as naringenin (Jiang and Morgan, 2005). 
Even though metabolic engineering is becoming more and more valuable it still faces sev-
eral challenges in order to mature as an area of engineering. This is largely due to the ex-
pensive methods employed, like chromatographic methods, to measure cellular compound 
production during the design process which causes the design-build-test cycles are excru-
ciatingly long and may take up to several years in order to develop a strain with the desired 
characteristics. In order to counteract this problem, scientists are developing biosensors to 
get fast and direct readings of specific metabolite concentrations. It has been previously 
reported that construction of TF based biosensors is a viable option for detection of secon-
dary metabolites from the phenylpropanoid pathway such as vanillin, naringenin, benzoate 
and various other metabolites (Rogers, Taylor and Church, 2016) it is safe to assume that a 
similar system can be built for L-phenylalanine detection in yeast since it has not been 
done before in eukaryotic microorganisms, but only in bacteria such as E. coli (Mahr et al., 
2016).  
 
There has been a previous research done in the use of prokaryotic small molecule binding 
transcriptional activators and their use in biosensor design in S. cerevisiae. In  nature bacte-
rial transcriptional activation can take place when a transcriptional activator binds to a des-
ignated operator site in the promoter and by this enhancing the ability to guide RNA poly-
merase to the promoter and thus activate gene transcription or alternatively by directly in-
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teracting with the RNA polymerase itself in order to initiate transcription. In the given re-
search specifically researchers implemented a prokaryotic transcriptional activator from 
bacteria in order to construct a biosensor for sensing cis,cis-muconic acid (CCM) in the 
budding yeast S. cerevisiae. The CCM molecule is an intermediate in the aromatic com-
pound precursor (Skjoedt et al., 2016).  
 
1.5 Biosensor design 
A general design for constructing such biosensors was made using a multiparametric engi-
neering strategy. The biosensor design consisted most importantly of a CYC1 promoter 
which has been reported to be a fitting promoter for introducing other non-native TF bind-
ing sites in the yeast genome A BenM sequence, which is a transcriptional regulator acti-
vated by CCM and belongs to the prokaryotic family of LysR-type transcriptional regula-
tors (LTTR‟s). The sequence was introduced in the first so called TATA box (T1) position 
of the CYC1 promoter yielding a CYC1p_BenM_T1 promoter. The reporter molecule cho-
sen was GFP, so a GFP gene was added after the CYC1p and CYC1p_BenM_T1 promot-
ers yielding a biosensor construct. After performing flow cytometry experiments to meas-
ure GFP fluorescence output and concluded that the construct with the CYC1p_BenM_T1 
produced a GFP response when CCM was present in the medium compared to the CYC1p 
promoters which produced only background autofluorescence.  
This biosensor design was further tested by integrating various other LTTR family TR‟s 
such as FdeR,cPcaQ ArgP and MdcR native to various bacterial species and activated by 
naringenin, protocathecuic acid, L-arginine and malonic acid, respectively. The DNA se-
quences for all these TR‟s where integrated into the T1 location of the CYC1p promoter 
just as it was done with BenM. The results showed that all TR‟s introduced in the 
CYC1p_X_T1, with X representing each of the TR‟s, activated GFP expression if their 
respective inducing molecule was present in the medium thus showing that the biosensor 
design discussed is viable which was further backed up by high pressure liquid chromatog-
raphy (HPLC) experiments combined with slow cytometry showing a 98% correlation be-
tween CCM production titers and GFP fluorescent output (Skjoedt et al., 2016).  
The TyrR protein is native to E. coli and plays both the role of a transcriptional repressor 
and transcriptional activator for various genes involved in aromatic amino acid production. 
The TyrR has at least eight transcriptional units and can interact with all three of the aro-
matic amino acids yielded from the Shikimate pathway, ATP and the alpha subunit of 
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RNA polymerase. TyrR protein consists of three functional domains (N-terminal domain, 
Central domain and a C-terminal domain).  
The N-terminal domain plays the main role in gene expression activation, and consists of 
three (ACT, PAM, DIM) regions. The ACT region is thought to be responsible for the 
binding of aromatic amino acids that are involved in activation of gene expression. The 
PAM region is responsible for the binding of αCTD which is important for the initiation of 
gene transcription. Whereas the DIM is a dimerization motif of the TyrR protein which has 
a tendency to form dimers when overexpressed (Pittard, Camakaris and Yang, 2005). 
The Central domain of the TyrR protein plays no role in the transcriptional activation but is 
involved in ATP binding and hexamerization. It consists of an ATP binding sites, an ATP-
dependent tyrosinase binding site and a hexamerization region. ATP helps to increase 
TyrR protein affinity by around four times. The ATP-dependent tyrosinase binding site is 
integral for the tyrosine mediated repression and hexamerization. When TyrR protein is 
overproduced in the presence of tyrosine and ATP it forms hexamers. The central region 
also has autokinase, autophosphotase and phosphatase activity although the exact roles 
these activities play in repression have yet to be found. But it is known that in the presence 
of either tyrosine or phenylalanine the phosphatase activity is inhibited (Pittard, Camakaris 
and Yang, 2005). 
The C-terminal domain consists of two regions (DIM and HXH). The DIM region is in-
volved in dimerization of the TyrR protein. The HXH region is a classical helif-turn-helix 
DNA-binding motif and plays the main role in the recognition of the so called “TyrR box” 
DNA sequences which plays an integral part in gene regulation by the TyrR protein 
(Pittard, Camakaris and Yang, 2005). 
The TyrR boxes are DNA sequences that are bound by the TyrR protein. Altogether there 
have been 17 TyrR boxes identified thus far for the eight characterized members of the 
regulon. All the TyrR box sequences are related to the TGTAAAN6TTTACA palindrome. 
The TyrR boxes are split into weak and strong, where the strong boxes activate gene tran-
scription whereas the weak boxes repress gene transcription. In operons containing these 
weak and strong boxes near or inside of the promoters provides a sensing mechanism for 
aromatic amino acids.  
In order to initiate gene activation by TyrR four conditions have to be met which include 
an imperfect promoter able to be activated, TyrR strong box appropriately located in per-
spective to the promoter, one of the three aromatic amino acids in combination with the 
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TyrR protein and the αCTD region of RNA polymerase (Pittard, Camakaris and Yang, 
2005). 
Although TyrR binds effectively to the strong boxes in the absence of aromatic amino ac-
ids, it cannot recruit an RNA polymerase without an aromatic amino acid present. If 
phenylalanine is present and tyrosine is absent in the media the TyrR protein forms dimers 
and can bind to the TyrR strong box and recruit the αCTD of RNA polymerase thus acti-
vating transcription of a gene. Both tyrP and mtr genes are activated by the TyrR protein in 
the presence of phenylalanine (Pittard, Camakaris and Yang, 2005), suggesting that their 
corresponding TyrR boxes could be viable mechanisms for biosensor construction. 
In the research performed by Regina Mahr and her team they performed the screening of 
an E. coli promoter library to find the best promoter for the construction of a phenylalanine 
biosensor. They identified a promoter from the mtr gene encoding for L-tryptophan trans-
porter to be suitable for the biosensor design since the mtr is activated by the TyrR protein 
if phenylalanine is present in the growth medium thus initiating gene transcription. The 
biosensor construct was designed in a way where the mtr promoter was located down-
stream from a TyrR strong box which facilitates the TyrR protein binding in the presence 
of phenylalanine and thus initiating the transcription of the venus fluorescent reporter gene 
(Mahr et al., 2016).  
The authors of this paper stress that there are five parameters that require attention when 
screening for optimal promoter designs for biosensor construction which include, organism 
adaption to its growth medium, the mode of gene expression activation, uptake and catabo-
lism of target effector molecules, fluorescent protein maturation and carefully chosen com-
position of the growth medium in order to avoid high autofluorescence. To enrich promot-
ers and get rid of constitutively activated promoters a screening method where cells with 
high fluorescent output when induced were chosen and choosing promoters with low fluo-
rescent output when target effector is not present. This strategy yielded enriched promoters 
in the presence of L-phenylalanine. It was shown that the given mtr promoter can be em-
ployed for L-phenylalanine biosensor construction (Mahr et al., 2016). 
Whereas the screening process suggested for selection of negatively regulated promoters in 
the presence of the chosen effector. This means that promoter‟s with low fluorescence 
when the effector is present are chosen and in the next round of screening promoters exhib-
iting high fluorescence when the effector is absent where chosen.  
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The two promoters suggested for L-phenylalanine biosensor construction where suggested 
mtr and TyrP, but only mtr was chosen because it has been established that the TyrP pro-
tein has 10-fold lower gene expression levels in the presence of L-phenylalanine in com-
parison with the mtr promoter (Mahr et al., 2016).  
The L-phenylalanine biosensor in S. cerevisiae is based on TF‟s and will consist of two 
genetic constructs TF and reporter protein coding sequence. First construct contains TyrR 
regulon coding sequence which will function as the transcription factor of the biosensor 
activated by L-phenylalanine. Second construct consists of GFP protein coding sequence 
regulated by the CYC1p promoter in a similar fashion as done by Mette L Skjoedt and his 
team (Skjoedt et al., 2016). The CYC1p promoter contains a mtr strong box in its T1 posi-
tion yielding CYC1p_T1_TyrR promoter (Skjoedt et al., 2016), (Mahr et al., 2016) which 
is bound by the TyrR regulon dimer formed in the presence of L-phenylalanine and thus 
initiating transcription of GFP. 
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2 THE AIMS OF THE THESIS 
The general aim of my BSc thesis was to design and construct L-phenylalanine biosensor 
for the yeast Saccharomyces cerevisiae. The more specific aims of the work are as follows: 
 Establishing Gibson assembly methodology in TUIT SynBio laboratory. 
 Design a functional biosensor for L-phenylalanine. 
 Construct and assemble the biosensor by: 
o Construction of the TyrR regulon containing genetic construct regulated by 
varying promoters (pFCY2 and CYC1p) and transcription terminator 
(tADH1). 
o Integration of the TyrR genetic construct into the S. cerevisiae genome. 
o Assembly of the CYC1p_T1_TyrR promoter containing the TyrR strong 
box transcription activation site. 
o Construction of the reporter protein (GFP) construct regulated by two pro-
moters: CYC1p_T1_TyrR and CYC1p as the reference and transcription 
terminator (tADH1). 
o Integration of the reporter protein genetic construct into the S. cerevisiae 
genome. 
 Testing of the newly constructed biosensor containing S. cerevisiae strain in 64-
well plate reader fluorescence measurement experiments. 
 Characterization of the newly constructed S. cerevisiae biosensor strain in Bio-
reactor cultivation experiments. 
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3 EXPERIMENTAL PART  
3.1 MATERIALS AND METHODS 
3.1.1 Recombinant DNA assembly and plasmid construction  
Here the author would like to explain the techniques used in the construction of biosyn-
thetic DNA pathways leading to the creation of the L-phenylalanine biosensor in S. 
cerevisiae.  
Standard DNA manipulation was carried out using polymerase chain reaction (PCR), DNA 
purification from the agar, enzymatic digestion of plasmids and plasmid extraction from 
bacterial cells. This also includes plasmid digestion for integration into the S. cerevisiae 
genome. DNA sequencing services were provided by EBK DNA sekveneerimise tuumik-
labor. All the plasmids (pRS303 and pRS306) were kindly provided by LoogLab (Univer-
sity of Tartu, Tartu, Estonia).  
 
First construct containing the TyrR regulon was integrated into the pRS303 plasmid pro-
vided by the SynBio Era laboratory of Tartu University. All the genetic parts like the TyrR 
gene sequence was synthesized by IDT (Integrated DNA Technologies, Coralville, USA). 
Promoters pFCY2 and CYC1p and tADH1 terminator sequences were taken from iGem 
(International Genetically Engineered Machinery competition) distribution kit 2017 (iGem, 
Cambridge, USA).  The pRS303 plasmid was digested with FD (FastDigest) EcoRI 
(FD0274) and FD Xba1 (FD0684) enzymes (Thermo Fisher Scientific, Waltham, USA) at 
37°C for 1 h. The promoters (CYC1p and pFCY2), (primers 1-4, Table of primers, Appen-
dix), gene (TyrR) (primers 5 and 6 or 6 and 7, Table of primers, Appendix) and terminators 
(tADH1), (primers 10 and 11, Table of primers, Appendix)were PCR amplified to intro-
duce homologous (~20 bp) overhang sequences for each of the respective construct parts. 
The digested plasmids and the PCR amplified products were purified using gel electropho-
resis. The samples where loaded in 1% agar gel and electrophorated for 30 min at 125 V 
and 400 mA. The extracted DNA fragments encased within the agar gel where gel purified 
using FavorPrep GEL/PCR Purification Mini Kit (FAGCK001-1), (FavorGen Biotech 
Corp, Vienna, Austria). The whole construct was assembled into the pRS303 plasmid fol-
lowing the Gibson assembly protocol (E5510) provided by NEB (New England BioLabs 
incorporated, Ipswich, USA) for assembly of four to six DNA fragments and incubated at 
50°C for 1 h. The newly assembled construct was transformed into E. coli for plasmid am-
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plification by initially thawing the competent bacterial cells on ice. 50 µL of thawed cells 
where mixed with 1 µL of constructed plasmid DNA and left on ice for 30 min. This was 
followed by 2 min of heat shock at 42°C and again put on ice for 2 min after which cells 
where mixed with 400 µL of LB media and incubated at 37°C for 30 min. The process was 
continued by centrifugation of the grown cells at 6000rpm for 1min and the supernatant 
was removed. Cells were resuspended in the remaining media and plated on LB+AMP 
plates overnight at 37°C incubation chamber. The selected bacterial colonies were grown 
overnight at 37°C in the shaking incubation chamber in 5 ml of LB liquid media with 5 µL 
of AMP antibiotic added to the medium. Plasmid was rescued after overnight bacterial 
incubation using FavorPrep Plasmid Extraction Mini Kit (FAPDE300), (FavorGen Biotech 
Corp, Vienna, Austria) according to the protocol provided by the manufacturer. The verifi-
cation of the assemblies was tested using digestion enzymes FD Xba1 and FD Pst1 
(FD0615), (Thermo Fisher Scientific, Waltham, USA) and incubated at 37°C for 1 h after 
which the digested samples were gel electrophorated. The previously extracted plasmid 
from the LB+AMP liquid colonies were digested using FD-Pfl23II (FD0854), (Thermo 
Fisher Scientific, Waltham, USA) at 37°C for 1h to digest the plasmid in the middle of the 
HIS resistance marker. The digestion enzyme was heat inactivated at 65°C for 5min as 
described by the provided protocol which came with the enzyme. The digested plasmid 
transformed into the yeast genome following the protocol described by J.H. Hegemann and 
S.B. Heick (Radamson, 2018). After incubation at 30°C for 3-5 days the yeast colonies 
were harvested. The correct integration of the construct was tested using PCR amplifica-
tion of the construct of interest and via genetic sequencing. This yielded SBY65 and 
SBY66 yeast strains with pFCY2 and CYC1p promoters for respective yeast strain inte-
grated into the genome. Positive colonies were re-plated on a new YPD+HIS plates and 
grown at 30°C for two days. Stocks were made by mixing 250 µL of 60% glycerol solution 
with 750 µL of YPD medium and the subsequent yeast colonies were tested by PCR ampli-
fication of the TyrR construct from the genomic DNA. To extract the genomic DNA from 
yeast cells, a colony was resuspended in 30 µL of NaOH (Sodiem Hydroxide, 20mM). Put 
in 100°C for 10 min and then placed on ice. After which they were centrifugated at 18 G 
(gravitational force of earth) for 1min. The supernatant was used for PCR amplification for 
confirmation (~2 µL per reaction). The positive colonies were suspended in this medium 
and stored at -80°C freezer. 
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In order to introduce the mtr strong TyrR box into the CYC1p promoters T1 position over-
lapping PCR method was employed. Initially two fragments of CYC1p were ordered from 
IDT (Integrated DNA Technologies, Coralville, USA) where the promoter was split in two 
segments. First segment contained the CYC1p fragment from the beginning of the promo-
ter up till the T1 position where the strong box should be further known as CYC1p_T1, 
(primers 14 and 15, Table of primers, Appendix). The second segment consisted of the 
CYC1p promoter T1 position with the strong box inside up till the end of the CYC1p pro-
moter DNA sequence further known as T1_TyrR, (primers 16 and 17, Table of primers, 
Appendix). After PCR amplification of each of these fragments were electrophorated in 
1% agarose gel and extracted by using the FavorPrep GEL/PCR Purification Mini Kit 
(FAGCK001-1), (FavorGen Biotech Corp, Vienna, Austria). Later, overlapping PCR was 
employed for the assembly of these fragments forming CYC1p_T1_TyrR promoter using 
the following reaction (Table 1) and PCR program described below (Table 2). The buffer 
used for the PCR reaction is DreamTaq buffer (10x), (B65), (Thermo Fisher Scientific, 
Waltham, USA). Correct fragment amplification and assembly was confirmed using gel 
electrophoresis and DNA sequencing. 
 
Reagents 1x reaction 
DreamTaq buffer (10x) 25 µL 
CYC1p_T1 2 µL 
T1_TyrR 1 µL 
Destilled water 17 µL 
2,5 µL of each primer (primers 14 and 17, Table of primers, Appendix) added into the reaction 
after the first PCR cycle 
Table 1. Reaction mixture of for the overlapping PCR for CYC1p_T1 and T1_TyrR assembly into 
CYC1p_T1_TyrR promoter 
 
 
 
 
 35cycles 
Table 2. Overlapping PCR program for assembling CYC1p_T1_TyrR promoter 
 
Program Time Temperature 
Denaturation 3 min 95°C 
Denaturation 30 sec 95°C 
Annealing 20 sec 52°C 
Extension 1 min 72°C 
Hold ∞ 4°C 
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Second construct containing the CYC1p and CYC1p_T1_TyrR promoter sequences where 
integrated into the pRS306 plasmid already containing the GFP and CYC1t terminator se-
quences provided by the SynBio Era laboratory of Tartu University. All promoter 
(CYC1p_T1_TyrR and CYC1p) sequences were synthesized by IDT (Integrated DNA 
Technologies, Coralville, USA). The promoters (CYC1p_T1_TyrR and CYC1p), (primers 
20 and 21, Table of primers, Appendix) and the plasmid pRS306 (primers 18 and 19, Table 
of primers, Appendix) where PCR amplified to introduce homologous (~20bp) overhang 
sequences for each of the respective construct parts. The PCR amplified products where 
purified from the using gel electrophoresis. The samples were loaded in 1% agar gel and 
electrophorated for 30 min at 125 V and 400 mA. The extracted DNA fragments encased 
within the agar gel were gel purified using FavorPrep GEL/PCR Purification Mini Kit 
(FAGCK001-1), (FavorGen Biotech Corp, Vienna, Austria) for the CYC1p and 
CYC1p_T1_TyrR sequences and the plasmid using Zymo-Spin 1 DNA extraction columns 
(C1003-50), (Irvine, USA). The promoter sequences were assembled into the pRS306 
plasmid following the Gibson assembly protocol (E5510) provided by NEB (New England 
BioLabs incorporated, Ipswich, USA) for assembly of two to three DNA fragments and 
incubated at 50°C for 1 h. The newly assembled construct was transformed into E. coli for 
plasmid amplification by initially thawing the competent bacterial cells on ice. 50 µL of 
thawed cells where mixed with 1 µL of constructed plasmid DNA and left on ice for 30 
min. This was followed by 2min of heat shock at 42°C and again put on ice for 2 min after 
which cells where mixed with 400µL of LB media and incubated at 37°C for 30 min. The 
process was continued by centrifugation of the grown cells at 6000 rpm for 1 min and the 
supernatant was removed. Cells where resuspended in the remaining media and plated on 
LB+AMP plates overnight in a 37°C incubation chamber. The selected bacterial colonies 
were grown overnight at 37°C in the shaking incubation chamber in 5 ml of LB liquid me-
dia with 5 µL of AMP antibiotic added to the medium. Plasmid was rescued after over-
night bacterial incubation using FavorPrep Plasmid Extraction Mini Kit (FAPDE300), (Fa-
vorGen Biotech Corp, Vienna, Austria) and the protocol provided with it. The verification 
of the assembled was tested using colony PCR by amplifying the whole genetic construct 
(CYC1p/CYC1p_T1_TyrR + GFP + CYC1t). Other half of the colony was grown over-
night at 37°C in the shaking incubation chamber in LB 5 ml of liquid media with 5 µL of 
AMP antibiotic added to the medium. Plasmid was rescued after overnight bacterial incu-
bation using Zymo-Spin 1 DNA extraction columns (C1003-50), (Irvine, USA) and the 
protocol provided with it. The extracted plasmid was digested using FD-Apa1 (FD1414), 
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(Thermo Fisher Scientific, Waltham, USA) at 37°C for 1 h. The digestion enzymes where 
heat inactivated at 65°C for 5min as described by the provided protocol which came with 
the enzyme. The digested plasmid was transformed into the SBY65 and SBY66 yeast 
strain genome following the protocol described by J.H. Hegemann and S.B. Heick 
(Radamson, 2018). After incubation at 30°C for 3-5 days the yeast colonies where har-
vested. The correct integration of the construct was tested using PCR amplification of the 
construct of interest and via genetic sequencing. Positive colonies where re-plated on new 
YPD+URA plates and grown at 30°C for two days. Stocks were made by mixing 250 µL 
of 60% glycerol solution with 750 µL of YPD medium and the subsequent yeast colonies 
where suspended in this medium and stored at -80°C freezer. 
 
3.1.2 64-well plate reader experiments  
The microplate reader experiment was designed to measure the optimum functional range 
of the phenylalanine biosensor. Each test condition should be performed in triplicates. The 
yeast strains with the biosensor constructs were inoculated in DELFT minimalistic mineral 
media with ranging phenylalanine concentrations (0.2-4 mM) since previous literature has 
reported a similar functional ranges in case of E. coli (Mahr et al., 2016). The conditions 
were divided as follows:  
1) Control strain and functional biosensor strain DELFT+ L-Phe (0.2 mM) media 3x 
2) Control strain and functional biosensor strain DELFT+ L-Phe (1 mM) media 3x 
3) Control strain and functional biosensor strain DELFT+ L-Phe (2 mM) media 3x  
4) Control strain and functional biosensor strain DELFT+ L-Phe (2.5 mM) media 3x 
5) Control strain and functional biosensor strain DELFT+ L-Phe (4 mM) media 3x  
Multiple control wells were used as follows: 
6) Only DELFT media 3x 
7) Each yeast strain in pure DELFT media 3x 
8) All yeast strains in DELFT media with tryptophan (2 mM) 3x 
This was done since L-tryptophan may cause unwanted TyrR dimerization (Pittard, 
Camakaris and Yang, 2005) and thus initiation of GFP transcription. Pure DELFT media 
with inoculated yeast cells were used in order to measure background fluorescence and 
help in determining the biosensor functional range. The optical density (OD) and fluores-
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cence where measured each hour for a 24h long period and the data were analysed using 
Microsoft Excel computer program. 
3.2 RESULTS & DISCUSSION 
Here the author would like to explain the results yielded after DNA assembly steps and 64-
well plate reader experiments just as well discuss the implications of each result. 
3.2.1 Genetic construct assembly containing TyrR regulon sequence 
The TyrR regulon will function as the sensing element of the biosensor. TyrR in the 
presence of L-phenylalanine will dimerise and bind to the CYC1p_T1_TYR promoter 
(Figure 17). To vertify correct DNA assembly enzymathic digestion and gel 
electrophoresis were employed (Figure 4). Two fragments were expected. The ~5 kb 
bigger fragment containing the digested pRS303 plasmid with the TyrR construct 
integrated. The DNA ladder employed is GeneRuler 1 kb Plus DNA Ladder 
(MAN0013047), (Thermo Fisher Scientific, Waltham, USA) and GeneRuler 50 bp DNA 
Ladder (SM037), (Thermo Fisher Scientific, Waltham, USA).. Proving that the Gibson 
assembly (E5510) performed was successful. The ~600bp size difference can be explained 
by the fact that one of the samples has a CYC1p promoter (290 bp) and the other contain-
ing a pFCY2 promoter (900 bp) accordingly. 
 
Figure 4. Gel electrophoresis results after construct plasmid digestion wit Xba1 and Pst1 enzymes 
(~4-4.5 kB) where A – construct containing pFCY2 and B – construct containing CYC1p. 
 
After bacterial transormation was done, yielded colonies where tested by PCR amplifying 
the TyrR DNA sequence which is ~1500 bp long (Figure 5). The DNA ladder employed is 
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GeneRuler 1 kb Plus DNA Ladder. The results seem to be positive thus confirming the 
plasmid has been correctly absorbed by the E. coli bacteria. The amplification results 
showed expected sizes. 
 
Figure 5. Amplification of the TyrR DNA sequence (~1.5 kB) from transformed E. coli bacterial 
colonies (primers 6 and 7 for CYC1p containing, 5 and 6 for pFCY2 containing construct, Table of 
primers, Appendix) 
 
Lastly, after yeast transformation, the construct integration was confirmed by isolation of 
the yeast genomic DNA and PCR amplification of the TyrR gene sequence with the 
expected size of ~1500 bp (Figure 6). The DNA ladder employed is GeneRuler 1 kb Plus 
DNA Ladder. The results showed expected sizes. 
 
Figure 6. PCR amplified TyrR DNA sequence from yeast genomic DNA first well has the construct 
containing CYC1p and second has pFCY2(primers 6 and 7 for CYC1p containing, 5 and 6 for pF-
CY2 containing construct, Table of primers, Appendix). 
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3.2.2 CYC1p_T1_TyrR promoter assembly 
To assemble the CYC1p_T1_TyrR promoter each of the seperately PCR amplified DNA 
sequences (CYC1p_T1 ~142 bp and T1_TyrR ~212 bp) where electrophorated in 1% 
agarose gel (Figure 7). The DNA ladder employed was. The DNA ladder employed is 
GeneRuler 50 bp DNA Ladder. 
 
Figure 7. PCR amplified fragments of CYC1p_T1 (~142 bp), (primers 14 and 15, Table of primers, 
Appendix) and T1_TyrR (~212 bp), (primers 16 and 17, Table of primers, Appendix). 
The gel extraction was followed by overlapping PCR to assemble the CYC1p_T                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
1 and T1_TyrR fragments into the CYC1p_T1_TyrR promoter (~300 bp), (Figure 8). The 
PCR products were electrophorated and later verified using DNA sequencing which 
confirmed succesfull promoter construction. 
 
Figure 8. Gel picture of the overlapping PCR, (primers 14 and 17, Table of primers, Appendix  
sample reulting in the CYC1p_T1_TyrR promoter. 
29 
 
3.2.3 Genetic construct assembly containing the GFP reporter protein 
Initially the author tried assembling the individual CYC1p_T1_TyrR/CYC1p promoter 
(~300 bp), (primers 3 and 4, Table of primers, Appendix) with GFP gene (720 bp), (pri-
mers 12 and 13, Table of primers, Appendix), tADH1 terminator (350 bp), (primers 8 and 
9, Table of primers, Appendix) and the pRS304 plasmid (4443 bp), digested with FD 
EcoR1 and FD Bcu1, parts. The Gibson Assembly was done following the same guidlines 
as with the TyrR genetic construct for assembly of four to six parts. The parts were initially 
PCR amplified to introduce homologous regions for each of the respective parts to 
assemble and gel purified (Figure 9) including pRS304 digested plasmid (Figure 10). The 
DNA ladder employed is GeneRuler 1 kb Plus DNA Ladder. The fragments were within 
the expected size range. Confirming that the PCR amlification worked and homologous 
sticky ends should have been introduced. 
 
Figure 9. CYC1p construct fragment PCR amplification results. 
 
Figure 10. Plasmid‟s pRS304 digestion with EcoR1 and Bcu1. 
After the bacterial transformation colonies which grew where checked for whole construct 
(CYC1p/CYC1p_T1_TyrR+GFP+tADH1, ~1350 bp) correct assembly via colony PCR 
(primers 3 and 9, Table of primers, Appendix), (Figure 11).  
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Figure 11. Colony PCR to check for whole construct assembly. 
Aftter receiving the author troubleshoot, the reasons for the failure and PCR amplified GFP 
gene (720 bp) from its original source (Figure 12) and sent the purified GFP samples for 
DNA sequencing. The results showed that the GFP DNA sequence had undergon genetic 
mutations and the DNA sequence had frame shifted and thus rendered the GFP protein 
unfunctional. 
 
Figure 12. GFP (720 bp) gene amplification PCR result (primers 12 and 13, Table of primers, Ap-
pendix) 
After learning that the current GFP used is unfunctional the author opted for a different 
approach for CYC1p and CYC1p_T1_TyrR fragment integration into a plasmid so a 
construct which was already sequenced and confirmed was provided by the SynBio Era 
laboratory. It already consisted of pGAL1+GFP+tADH1+pRS306 construct. 
The promoters CYC1p (~280 bp) and CYC1p_T1_TYR (~320 bp), (Figure 13) and the 
plasmid GFP+CYC1t+pRS306 (~5350 bp), (Figure 14) were PCR amlified to introduce 
homologous overhangs for Gibson assembly. The PCR products where electrophorated and 
later extracted from the 1% agarose gel. The DNA ladder employed is GeneRuler 1 kb Plus 
DNA Ladder. The fragments had expected sizes. 
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Figure 13. PCR amplified CYC1p (~290 bp) and CYC1p_T1_TYR fragments (~320 bp), (primers 
20 and 21, Table of primers, Appendix). 
 
Picture 14. PCR amplified GFP+CYC1t+pRS306 plasmid (~5350bp), (primers 20 and 22, Table of 
primers, Appendix). 
These samples served as the basis for the Gibson assemblies performed. In order to 
increase the probability of a succesfull reaction the pRS306 plasmid was purified using 
Zymo-Spin 1 DNA extraction columns (C1003-50), (Irvine, USA) which has been shown 
to produce more highly concentrated DNA samples in comparison with the traditional 
columns used which allowed for optimum Gibson assembly conditions. They also served 
to verify that the PCR amplification of the constructs was correct.  
After Gibson assembly and bacterial transformation the correct assembly (Figure 15) was 
verified using colony PCR to amplify the whole construct 
(CYC1p/CYC1p_T1_TRY+GFP+CYC1t) which after electrophorated yielded fragments 
with the expected sizes (~1405 bp). The DNA ladder employed is GeneRuler 1 kb Plus 
DNA Ladder. 
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Figure 15. Colony PCR results for amplification of CYC1p/CYC1p_T1_TRY+GFP+CYC1t 
constructs (~1405 bp) confirming assembly (primers 19 and 20, Table of primers, Appendix). 
These results confirmed that the Gibson assembly was succesful and the author can extract 
the plasmids from the E. coli bacterial cultures.  
For integration into the S. cerevisiae genome the plasmid containing the aforementioned 
construct was digested with the FD Apa1 enzyme (~5.6 kB) and vertified using 
electrophoration (Figure 16). The DNA ladder employed is GeneRuler 1 kb Plus DNA 
Ladder. The results showed the expected DNA sizes except for the last one which is the 
same plasmid, but undigested funcioning as a control well. 
 
Figure 16. Digested CYC1p/CYC1p_T1_TRY+GFP+CYC1t+pRS306 constructs using FD Apa1 
enzyme. Letter C - undigested plasmid as control. 
Overall the current results are promising, but given the current time limitations the L-
phenylalanine biosensor will have to be tested and charcterized after the completion of the 
authors bachelor‟s program, which is a pitty. However, a design ofr the biosensor together 
with significant progress towards the construction of the sensor has been made (Figure 17). 
The L-phenylalanine biosensor consists of two parts – the transcription factor and the 
reporter gene (GFP) construct. After TyrR DNA sequence into the TyrR protein it can 
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recognize L-phenylalanine in the intracelullar space and dimerize. The dimerized TyrR 
binds to the TyrR strong box also known as mtr strong box (Mahr et al., 2016) embedded 
within the T1 position of the CYC1p_T1_TyrR promoter and now can recruit the αCTD 
subunit of RNA polymerase and thus activate GFP gene transcription and produce a green 
fluorescent output. 
 
Figure 17. L-phenylalanine biosensor design consisting of a TyrR transcription factor construct and 
a reporter construct employing the CYC1p_T1_TyrR promoter capable of being bound by a 
dimerized TyrR protein in the presence of L-phenylalanine and initiating GFP transcription. 
 
After succesful biosensor characterization many of the hypotheses descibed below can be 
verified or disproven. This will provide valuable insight for further various yeast based 
biosensor construction attempts. Especially for the use in selecting strains with upregulated 
aromatic amino acid or their derivative production.  
By using the general biosensor design described in this thesis poses two limiting factors. 
First being whether or not the transcription factor of choice is native to the host organism 
and thus largely likely that functional or to some other microorganism. Using prokaryotic 
microorganism transcription factors have to be tested in yeast to determine wheather or not 
the biosensor is functional since its not known wether or not they undergo any post-
translational modifications in eukaryotic cells thus rendering them unfunctional or 
distorting their functionality otherwise. The only family of prokaryotic transcriptional 
factors sure to function in yeast are LysR-type transcriptional regulators (LTTR‟s) which 
has been previously proven to work (Skjoedt et al., 2016). 
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In order to make the biosensor useful it can be tested in other yeast strains designed for 
increased L-phenylalanine or its derivative production. The use of the biosensor could be 
widely used for adaptive laboratory evolution of such strains thus eliminating the need for 
alternative and expensive screening methods such as chromatography. The price, time and 
manpower for strain selection and evolution for increased target compound production 
would be easier then ever. The author suggests the biosensor screening method in the 
future to make the process more cost efficient and yielding. 
It is also of interest to consider the fact that the CYC1p promoter employed in construction 
consists of two TATA box regions where the same or differing transcription factor binding 
sites can be employed thus allowing the construction of biosensors which function based 
on various logic gate systems and would allow for more specific conditions to be observed 
in very specific celullar stimuli. The results could still be measured using the fluorescent 
output at various induction conditions.  
Overall transcription factor based biosensors have a lot of potential for both research and 
industrial use as long as the person understands the concepts necessary for its construction 
and has the neccesarry facilities for its development. 
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SUMMARY 
Over the time of developing this project the author has learnt a multitude of genetic 
manipulation techniques and developed a thorough understanding of experimental process 
planning as well as deepened the knowledge about the mechanisms involved in metabolic 
pathways and cell survival. 
The Gibson assembly method was succesfully established in the SynBio Era laboratory and 
is currently being employed in a multitude of projects being developed there. 
A functional biosensor design has been succesfully developed based on previously done 
research. The design has been described in more detail in the „Results & Discussion“ part 
of this thesis paper. 
The genetic pathway for TyrR regulon prouction in yeast has been succesfully developed 
and integrated within the S. cerevisiae genome. It has been confirmed by growing on 
selection plates containing the respective marker (LEU) and by DNA sequencing. 
The CYC1p_T1_TyrR promoter has been assembled and verified to contain the TyrR 
strong box for TyrR regulon binding in its first TATA box via DNA sequencing. The 
constructed promoter has been succesfully integrated into the genetic construct containing 
the GFP coding sequence in parallel with the usual CYC1p promoter used as the control 
for measurments. The constructed plasmid has been verified using amplification PCR and 
DNA sequencing techniques. The integration of these sequence into the S. cerevisiae 
genome is still undergoing. 
The characterization and functional range determination of the biosensor is still yet to be 
done in the future in both 64-well plate reader experiments and bio-reactor cultivation 
experiments. 
In retrospect the project had its hurdles and problems, but with the newly developed 
troubleshooting capabilites these problems have been identified and succesfully overcome. 
All the goals could not be acieved because of time constraints, but the potential of the 
biosensor use in close future is likely as long as the finishing steps of characterization are 
performed. 
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Appendix 
I. Table of primers 
1 pFCY2_F CGCGGTGGCGGCCGCTCTAGCTAGAGATCTAACACTGATGAAAAG 
2 pFCY2_R CCTATCCTCTATTATAACGATTTATAA-
GAATGCGTCTGGAAGTCTTTTG 
3 CYC_amp_F 
CGC GGT GGC GGC CGC TCT AGA GCG TTG GTT GGT GGA TCA A 
 
4 CYC_amp_R 
TCC TCG CCC TTG CTC ACC ATT TAG TGT GTG TAT TTG TGT TTG C 
 
5 TyrR_FCY_F TCTATTATAACGATTTATAAGAATGCGTCTGGAAGTCTTTTG 
6 TyrR_R AGTCAGAAGAAGAACGAAGAAGCTTTGGACTTCTTCGCCA 
7 TyrR_CYC_F AACACAAATACACACACTAAATGCGTCTGGAAGTCTTTTG 
8 tADH1_CYC_F TGGACGAGCTGTATAAGTAAAGCTTTGGACTTCTTCGCCA 
9 tADH1_CYC_R CGAAATTCCCCTACCCTATGAATTCGATATCAAGCTTATC 
10 tADH1_TYR_F AGTCAGAAGAAGAACGAAGAAGCTTTGGACTTCTTCGCCA 
40 
 
11 tADH1_TYR_R ATGTACTAGTAGCGGCCGCTAATTCGATATCAAGCTTATC 
120 GFP_F 
AAC ACA AAT ACA CAC ACT AAA TGG TGA GCA AGG GCG AGG A 
 
13 GFP_R 
TGG CGA AGA AGT CCA AAG CTT TAC TTA TAC AGC TCG TCC ATG 
CC 
 
14 CYCp_T1_F 
ATATATGAATTCGCGGCCGCTTCTAGAGAGCGTTGGTTGGTGGATC  
 
15 CYCp_T1_R 
TATTTTACATATGTGTCAGCACTAAAGTTGCCTGGCC 
 
16 T1_TYR_F 
TGTAAAATACAGGCATATATATATGTGTGCGACGACACATGATC 
 
17 T1_TYR_R 
TATAAACTGCAGCGGCCGCTACTAGTATTAGTGTGTGTATTTGTGT 
 
18 pRS306_F 
GGCGAATTGGAGCTCTAGTAAGCGTTGGTTGGTGGATCAA 
 
19 pRS306_R 
TCTAGAATCCGGGGTTTTTTTTAGTGTGTGTATTTGTGTTTGC 
 
20 306_CYC_F 
AACACAAATACACACACTAAAAAAAACCCCGGATTCTAGA 
 
21 306_CYC_R 
TTGATCCACCAACCAACGCTTACTAGAGCTCCAATTCGCC 
 
22 M13_R 
CAGGAAACAGCTATGAC 
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